These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20874225)

  • 21. Suppressive effect of anti-alpha 1-antichymotrypsin serum on pulmonary fibrosis induced by phorbol myristate acetate in vivo.
    Nagareda T; Tanaka A; Terada N; Imakon Y; Shiomi H; Matsubara H; Noro A; Nishizawa Y
    Lab Invest; 1995 Oct; 73(4):541-6. PubMed ID: 7474926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
    Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
    Sakamoto H; Zhao LH; Jain F; Kradin R
    Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.
    Burdick MD; Murray LA; Keane MP; Xue YY; Zisman DA; Belperio JA; Strieter RM
    Am J Respir Crit Care Med; 2005 Feb; 171(3):261-8. PubMed ID: 15502109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.
    François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I
    J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
    Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR
    Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
    Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
    Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected].
    Krempaska K; Barnowski S; Gavini J; Hobi N; Ebener S; Simillion C; Stokes A; Schliep R; Knudsen L; Geiser TK; Funke-Chambour M
    Respir Res; 2020 Jan; 21(1):25. PubMed ID: 31941499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
    Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
    Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep.
    Organ L; Bacci B; Koumoundouros E; Barcham G; Kimpton W; Nowell CJ; Samuel C; Snibson K
    Exp Lung Res; 2015 Apr; 41(3):115-34. PubMed ID: 25531791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-level laser therapy attenuates lung inflammation and airway remodeling in a murine model of idiopathic pulmonary fibrosis: Relevance to cytokines secretion from lung structural cells.
    de Brito AA; da Silveira EC; Rigonato-Oliveira NC; Soares SS; Brandao-Rangel MAR; Soares CR; Santos TG; Alves CE; Herculano KZ; Vieira RP; Lino-Dos-Santos-Franco A; Albertini R; Aimbire F; de Oliveira AP
    J Photochem Photobiol B; 2020 Jan; 203():111731. PubMed ID: 31935633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glaucocalyxin A improves survival in bleomycin-induced pulmonary fibrosis in mice.
    Yang F; Cao Y; Zhang J; You T; Zhu L
    Biochem Biophys Res Commun; 2017 Jan; 482(1):147-153. PubMed ID: 27816453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas.
    Feola DJ; Garvy BA; Cory TJ; Birket SE; Hoy H; Hayes D; Murphy BS
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2437-47. PubMed ID: 20231397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease.
    Müller T; Fay S; Vieira RP; Karmouty-Quintana H; Cicko S; Ayata K; Zissel G; Goldmann T; Lungarella G; Ferrari D; Di Virgilio F; Robaye B; Boeynaems JM; Blackburn MR; Idzko M
    Oncotarget; 2017 May; 8(22):35962-35972. PubMed ID: 28415591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
    Ghebremariam YT; Cooke JP; Gerhart W; Griego C; Brower JB; Doyle-Eisele M; Moeller BC; Zhou Q; Ho L; de Andrade J; Raghu G; Peterson L; Rivera A; Rosen GD
    J Transl Med; 2015 Aug; 13():249. PubMed ID: 26231702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages.
    Zhao J; Okamoto Y; Asano Y; Ishimaru K; Aki S; Yoshioka K; Takuwa N; Wada T; Inagaki Y; Takahashi C; Nishiuchi T; Takuwa Y
    PLoS One; 2018; 13(5):e0197604. PubMed ID: 29782549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.
    Williamson JD; Sadofsky LR; Hart SP
    Exp Lung Res; 2015 Mar; 41(2):57-73. PubMed ID: 25514507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AAV6-Mediated IL-10 Expression in the Lung Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Kurosaki F; Uchibori R; Sehara Y; Saga Y; Urabe M; Mizukami H; Hagiwara K; Kume A
    Hum Gene Ther; 2018 Nov; 29(11):1242-1251. PubMed ID: 29598007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased hemoglobin-oxygen affinity ameliorates bleomycin-induced hypoxemia and pulmonary fibrosis.
    Geng X; Dufu K; Hutchaleelaha A; Xu Q; Li Z; Li CM; Patel MP; Vlahakis N; Lehrer-Graiwer J; Oksenberg D
    Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27624688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S100A4
    Li Y; Bao J; Bian Y; Erben U; Wang P; Song K; Liu S; Li Z; Gao Z; Qin Z
    Front Immunol; 2018; 9():1776. PubMed ID: 30127784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.